ICFP News & Insights

Medicines360: Creating Equitable Access

Nov 11, 2022

GUEST COLUMN:

Medicines360

by Tina Raine-Bennett

Our Mission is to catalyze equitable access to medicines and devices through product development, policy advocacy, and collaboration with global and U.S. partners

We are expanding access to our IUD in Africa, South and Southeast Asia, Central America, and the Caribbean, under the brand AvibelaTM

AVIBELA is manufactured in Belgium and supplied to global and local partners by Medicines360

Local partners lead distribution, training, and service delivery
AVIBELA is available at a subsidized access price for all units ordered through international procurement group catalogs or on behalf of eligible public sector programs.

For questions or to learn more about Avibela and about the new products and partnerships in our pipeline, visit Avibela.com, Medicines360.org, or email globalaccess@medicines360.org

 

Learn more about the Medicines360:

Explore More

ICFP 2025 Abstract Submissions Open 15 January

ICFP 2025 Abstract Submissions Open 15 January

World Religion Day Webinar: How Faith Leaders Can Communicate Evidence-based Family Planning Information

World Religion Day Webinar: How Faith Leaders Can Communicate Evidence-based Family Planning Information

Reflecting on Vibrant ICFP Community Conversations at the 8th Nigerian Family Planning Conference

Reflecting on Vibrant ICFP Community Conversations at the 8th Nigerian Family Planning Conference

Spread the Word

Save these graphics (in English, French, and Spanish) to share this opportunity with your networks—including researchers, practitioners, policymakers, advocates, and youth leaders—letting them know that the ICFP 2025 Call for Abstracts is open now through 15 March 2025.

Share the News

Let your networks know about the historic ICFP 2025 happening in Latin America for the first time ever in Bogotá, Colombia on 3–6 November 2025!

Download All: Horizontal | Square